Live feed07:30:00·6mPRReleasevia QuantisnowREGENXBIO Announces Alignment with FDA on Path Forward for NAVSUNLI™ BLA Resubmission for Accelerated Approval; First Potential Gene Therapy for MPS IIByQuantisnow·Wall Street's wire, on your screen.RGNX· REGENXBIO Inc.Health Care
